2017
DOI: 10.1016/j.vetmic.2017.08.019
|View full text |Cite
|
Sign up to set email alerts
|

Are vaccine strain, type or administration protocol risk factors for canine parvovirus vaccine failure?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(35 citation statements)
references
References 36 publications
0
34
0
1
Order By: Relevance
“…Although no statistically significant association was found between CPV genotype and vaccination status, the samples sizes for CPV-2a and CVP-2b genotypes were small, suggesting insufficient power to detect variations in vaccine protection against different genotypes. A recent Australian study found that the age at administration of the final CPV puppy vaccination was the most significant risk factor for vaccination failure and that there was no association between vaccine failure and the strain used in the vaccine's manufacture (CPV-2 or CPV-2b) [35]. To avoid any bias due to maternal antibodies in vaccinated dogs, samples within the age range of 9-16 weeks were removed from the study.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although no statistically significant association was found between CPV genotype and vaccination status, the samples sizes for CPV-2a and CVP-2b genotypes were small, suggesting insufficient power to detect variations in vaccine protection against different genotypes. A recent Australian study found that the age at administration of the final CPV puppy vaccination was the most significant risk factor for vaccination failure and that there was no association between vaccine failure and the strain used in the vaccine's manufacture (CPV-2 or CPV-2b) [35]. To avoid any bias due to maternal antibodies in vaccinated dogs, samples within the age range of 9-16 weeks were removed from the study.…”
Section: Discussionmentioning
confidence: 99%
“…Live attenuated parvovirus vaccines are safe and provide protective immunity when administered at appropriate intervals [18,34]. A major cause of vaccine failure is thought to be the administration of the final vaccine dose to puppies less than 16 weeks old, when maternal antibodies can interfere with the development of immunity, although many other causes are possible [24,35].…”
Section: Ofmentioning
confidence: 99%
“…CPV is transmitted through the oronasal route with the virus in faeces. Three to seven days following infection, the virus is shed in the faeces and clinical symptoms occur, as mentioned, in young dogs; adult dogs can stay asymptomatic with the help of immunity gained through vaccination or previous transmissions (1,5,8).…”
Section: Praca Oryginalnamentioning
confidence: 99%
“…Although infections can be subclinical, CPV can cause gastroenteritis, dehydration, immune suppression and death, and disease typically occurs in dogs under 6 months of age. Adults can also be affected (Allison et al, 2014;Altman et al, 2017;Ling et al, 2012;Mylonakis et al, 2016). Euthanasia is the leading cause of death from CPV in Australia (Ling et al, 2012) with 20,000 CPV cases estimated annually and higher reporting in rural and remote areas and lower socioeconomic regions (Kelman et al, 2019).…”
Section: Introductionmentioning
confidence: 99%